Cargando…
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire
BACKGROUND: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Approximately 50% of breast cancers are discovered at an early stage in patients for whom conservative surgery is indicated. Intraoperative localization of non-palpable breast lesions is...
Autores principales: | Veyssiere, Hugo, Dressaire, Margot, Pete, Raphaël, Pinard, Céleste, Molnar, Ioana, Abrial, Catherine, Ginzac, Angeline, Durando, Xavier, Tekath, Marielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357842/ https://www.ncbi.nlm.nih.gov/pubmed/37468859 http://dx.doi.org/10.1186/s12885-023-11190-w |
Ejemplares similares
-
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
por: Wong-Chong, Jonathan, et al.
Publicado: (2021) -
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2021) -
Radio-frequency identification (RFID) tag localisation of non-palpable breast lesions a single centre experience
por: Almalki, Hend, et al.
Publicado: (2023) -
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study
por: Herrmann, Tressie, et al.
Publicado: (2021) -
Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
por: Ginzac, Angeline, et al.
Publicado: (2021)